Author

Diana R. Pereira

Institution: Centre for Human Drug Research

Observed institution: Centre for Human Drug Research

ORCID: 0000-0002-4258-648X

Observed ORCID: 0000-0002-4258-648X

OpenAlex ID: A5123638551

POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised, double-blind, placebo-controlled study

2026 · Digna T. de Bruin, Manon A. A. Jansen, et al. · Frontiers in Immunology · 1

Repeated intradermal lipopolysaccharide challenge responses in healthy volunteers: Implications for clinical pharmacology studies

2026 · Alexandra A. J. Sillé, Juliette A. van den Noort, et al. · British Journal of Clinical Pharmacology

Intravenous Lipopolysaccharide Challenge in Healthy Participants Reveals Pharmacodynamic Markers in Blood and Bone Marrow for Early‐Phase Oncology Drug Development

2026 · Igor Radanović, Ingrid Tomljanović, et al. · Clinical Pharmacology & Therapeutics

Works count: 3

Citation count: 1

H-index: 1

I10-index: